SMG-1 serves as a prognostic indicator for the radiotherapy response in head and neck squamous cell carcinoma xenografts and patients

• Wang Xiaofeng,
• Zou Yuxia,
• Ding Ren-Bo,
• Lyu Xueying,
• Fu Yuanfeng,
• Zhou Xuejun,
• Sun Zhihua,
• Bao Jiaolin

Affiliations

Wang Xiaofeng

["Department of Otolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Hainan Medical University, Haikou 571199, China"]

Zou Yuxia

["Department of Otolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Hainan Medical University, Haikou 571199, China"]

Ding Ren-Bo

["Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China"]

Lyu Xueying

["Cancer Centre, Faculty of Health Sciences, University of Macau, Macao 999078, China"]

Fu Yuanfeng

["Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China"]

Zhou Xuejun

["Department of Otolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Hainan Medical University, Haikou 571199, China"]

Sun Zhihua

["Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China","College of Animal Science and Technology, Shihezi University, Shihezi 832003, China"]

Bao Jiaolin

["Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China"]